1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Liposome

Liposome

Liposomes (NPs typically 100–500 nm in diameter) are fabricated from the self-assembly of phospholipids, which consist of a polar phosphate head group and hydrophobic lipid tails. In aqueous environments, the hydrophobic tails self-orient, resulting in a spherical structure comprised of an aqueous core surrounded by a lipophilic bilayer membrane. Liposomes are both biocompatible and biodegradable (e.g., at certain pH and temperature), which can be controlled by modifying the lipid composition. Furthermore, liposomes are amenable to various modifications that improve their efficacy as drug delivery carriers.

Liposome Related Products (1007):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-134541GL
    SM-102 (GMP Like)
    SM-102 (GMP Like) is SM-102 (HY-134541) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. SM-102 is an amino cationic lipid useful in the formation of lipid nanoparticles (LNPs). SM-102 has higher transfection efficiency. SM-102 plays an important role in the effectiveness of lipid nanoparticles (LNPs) in delivering mRNA therapeutics and vaccines.
    SM-102 (GMP Like)
  • HY-W440886
    DSPE-PEG3400-Biotin
    98.43%
    DSPE-PEG3400-Biotin is a phospholipid PEG for biotinylation. The amphiphilic property of the DSPE-PEG is useful for precision drug delivery and cancer therapy.
    DSPE-PEG3400-Biotin
  • HY-W783276
    18:1(11-cis) PC
    ≥99.0%
    18:1(11-cis) PC (Compound 18:1, c 11 (cis-vaccenic)) is an unsaturated fatty acid consisting of 18 carbon atoms with a cis double bond at the 11th position. 18:1(11-cis) PC can regulate membrane fluidity and is mainly used in the synthesis of artificial liposomes.
    18:1(11-cis) PC
  • HY-185373
    Paclitaxel liposome
    Paclitaxel liposome (Liposomal paclitaxel) is an antitumor agent targeting Estrogen Receptor. Paclitaxel liposome binds to overexpressed Estrogen Receptor to mediate receptor-specific endocytosis, and enters cells via macropinocytosis, caveolae-dependent and clathrin-dependent endocytic pathways. Paclitaxel liposome suppresses cell viability and tumor growth, and reduces the distribution of Paclitaxel (HY-B0015) in normal tissues. Paclitaxel liposome can be used for research related to breast cancer and locally advanced esophageal squamous cell carcinoma.
    Paclitaxel liposome
  • HY-W130610R
    Stearamide (Standard)
    Ginsenoside C-K (Standard) is the analytical standard of Ginsenoside C-K. This product is intended for research and analytical applications. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.
    Stearamide (Standard)
  • HY-142998
    Vaxfectin
    99.94%
    Vaxfectin is a second-generation cationic lipid-based suspension that adjuvants effectively both pDNA and protein-based vaccines. Vaxfectin can boost the immune response against a range of pDNA-expressed pathogenic antigens in vivo. Vaxfectin can increase IgG titers and give rise to an IL-6 dependent enhancement of the humoral immune response without altering the Th1 type immune response. Vaxfectin can be studied for vaccine formulation.
    Vaxfectin
  • HY-177846
    Liposomal Melatonin
    Liposomal Melatonin is a specialized delivery system that encapsulates melatonin within tiny liposomes. These liposomes act as protective shells, enhancing the absorption and bioavailability of melatonin. Melatonin is an antioxidant, anti-inflammatory, fr
    Liposomal Melatonin
  • HY-156448
    80-O14B
    99.56%
    80-O14B is a cationic lipid-like compound. 80-O14B can be used in mRNA delivery studies.
    80-O14B
  • HY-159716
    Lipid 50
    98.80%
    Lipid 50 (compound 50) is an ionizable lipid that can be used for the generation of lipid nanoparticles (LNPs). Lipid 50 is a carrier for both siRNA and mRNA.
    Lipid 50
  • HY-172706
    DSPE-PEG5000-RVG29
    DSPE-PEG5000-RVG29 is a PEG compound which composed of DSPE and a Rabies virus glycoprotein 29 (RVG29). RVG29 can bind specifically to the nicotinic acetylcholine receptor (nAChR) at the blood-brain barrier (BBB) and cross over the BBB.
    DSPE-PEG5000-RVG29
  • HY-153377
    Lipid 14
    Lipid 14 is an ionizable amino lipid. Lipid 14 delivers mRNA into target cells, significantly enhancing the in vivo expression efficiency and immunogenicity of mRNA. Lipid 14 can be used to synthesize lipid nanoparticles (LNPs). Lipid 14 can be used for studies of SARS-CoV-2 and Yersinia pestis.
    Lipid 14
  • HY-172271
    DSPE-PEG1000-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10)
    DSPE-PEG1000-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10) is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells.
    DSPE-PEG1000-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10)
  • HY-153137
    Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate
    98.71%
    Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate is a biodegradable lipid prepared by the conjugate addition of alkylamines to acrylates. Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate can be used in various drug delivery systems to deliver polynucleotides, siRNA for example.
    Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate
  • HY-176518
    ssPalmE-P4-C2
    98.81%
    ssPalmE-P4-C2 is a SS-cleavable and pH-sensitive lipid-like material (ssPalm) with a vitamin E‑scaffold. ssPalmE-P4-C2 improves gene knockdown activity against FVII with an ED50 of 0.5 mg/kg. ssPalmE-P4-C2 can be used to synthesize lipid nanoparticles (LNPs) for delivering siRNA to the hepatocyte. ssPalmE-P4-C2 can be used for the RNA therapies for dyslipidemia, hepatitis B/C infections and transthyretin amyloidosis research.
    ssPalmE-P4-C2
  • HY-167012
    306Oi9-cis2
    99.0%
    306Oi9-cis2 is an ionizable lipid. The ability of ionizable lipids to form unstable non-bilayer structures at acidic pH is key for endosomal escape and cytosolic delivery of RNA. 306Oi9-cis2 can be used in the preparation of liposomes.
    306Oi9-cis2
  • HY-147072
    1-Stearoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine sodium
    99.0%
    1-Stearoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine sodium is a glycerophospholipid.
    1-Stearoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine sodium
  • HY-172277A
    DSPE-PEG2000-R9
    DSPE-PEG2000-R9 is a PEG compound which composed of DSPE and a poly-arginine-9 peptide (R9). DSPE-PEG2000-R9 can be used for drug delivery.
    DSPE-PEG2000-R9
  • HY-144016
    16:0 EPC chloride
    99.93%
    16:0 EPC chloride, a P-O-ethyl derivative, is a saturated cationic lipid. 16:0 EPC chloride can serve as a DNA and RNA transfecting agent. 16:0 EPC chloride can be used as a co-adjuvant for preparing vaccines and promote drug delivery.
    16:0 EPC chloride
  • HY-177839
    Liposomal Coenzyme Q10
    98%
    Liposomal Coenzyme Q10 is a specialized delivery system that encapsulates coenzyme Q10 within tiny liposomes. These liposomes act as protective shells, enhancing the absorption and bioavailability of coenzyme Q10. Coenzyme Q10 (CoQ10), also called ubiquin
    Liposomal Coenzyme Q10
  • HY-149156
    Lipid C24
    99.90%
    Lipid C24 is a cationic ionizable lipid that can be used for synthesizing lipid nanoparticles. Lipid C24 can be used in the study of drug delivery.
    Lipid C24